Cingulate Inc. Reports Director Changes and Officer Appointments
Ticker: CINGW · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1862150
| Field | Detail |
|---|---|
| Company | Cingulate Inc. (CINGW) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-appointment, director-change, compensation
Related Tickers: CING
TL;DR
Cingulate Inc. filed an 8-K detailing director changes, officer appointments, and executive compensation updates.
AI Summary
Cingulate Inc. filed an 8-K on June 11, 2025, reporting on several key events that occurred on June 10, 2025. These include the departure and election of directors, the appointment of certain officers, and updates to compensatory arrangements for officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
Changes in board composition and executive appointments can signal shifts in company strategy, governance, and future operational direction.
Risk Assessment
Risk Level: medium — Changes in leadership and governance can introduce uncertainty and potential strategic shifts that may impact the company's performance.
Key Players & Entities
- Cingulate Inc. (company) — Registrant
- June 10, 2025 (date) — Earliest event reported
- June 11, 2025 (date) — Date of report
FAQ
What specific director positions saw changes?
The filing indicates the departure of directors and the election of new directors, but does not specify the exact positions affected in the provided text.
Were there any new officer appointments?
Yes, the filing explicitly mentions the appointment of certain officers.
What is the nature of the updates to compensatory arrangements?
The filing states there are updates to compensatory arrangements of certain officers, but the specific details are not provided in this excerpt.
Were any matters submitted to a vote of security holders?
Yes, the filing reports the submission of matters to a vote of security holders.
What is the primary business of Cingulate Inc.?
Cingulate Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Cingulate Inc. (CINGW).